{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:35:08Z","timestamp":1784774108084,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.ijcard.2008.08.001","type":"journal-article","created":{"date-parts":[[2008,9,16]],"date-time":"2008-09-16T09:16:59Z","timestamp":1221556619000},"page":"25-31","source":"Crossref","is-referenced-by-count":111,"title":["Impact of gender in primary prevention of coronary heart disease with statin therapy: A meta-analysis"],"prefix":"10.1016","volume":"138","author":[{"given":"Mario","family":"Petretta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Perrone-Filardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Chiariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2008.08.001_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.pcad.2003.08.001","article-title":"Epidemiology of coronary heart disease in women","volume":"46","author":"Bello","year":"2004","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ijcard.2008.08.001_bib2","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/CIRCULATIONAHA.107.181546","article-title":"Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update","volume":"115","author":"Mosca","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2008.08.001_bib3","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1046\/j.1525-1497.2003.20910.x","article-title":"Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women. A conceptual model","volume":"18","author":"Kim","year":"2003","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ijcard.2008.08.001_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1525-1497.2005.40155.x","article-title":"Ambulatory hypercholesterolemia management in patients with atherosclerosis. Gender and race differences in processes and outcomes","volume":"20","author":"Persell","year":"2005","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ijcard.2008.08.001_bib5","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1001\/jama.291.18.2243","article-title":"Drug treatment of hyperlipidemia in women","volume":"291","author":"Walsh","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2008.08.001_bib6","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/CIRCULATIONAHA.106.671826","article-title":"Usefulness of pravastatin in primary prevention of cardiovascular events in women: analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA study)","volume":"4","author":"Mizuno","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2008.08.001_bib7","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2008.08.001_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ijcard.2008.08.001_bib9","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/01.CIR.90.4.1679","article-title":"Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group","volume":"90","author":"Furberg","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2008.08.001_bib10","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2008.08.001_bib11","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1001\/jama.288.23.2998","article-title":"The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2008.08.001_bib12","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2008.08.001_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2008.08.001_bib14","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(06)69472-5","article-title":"Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial","volume":"368","author":"Nakamura","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2008.08.001_bib15","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2008.08.001_bib16","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study (WOSCOPS) Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"issue":"STB-38","key":"10.1016\/j.ijcard.2008.08.001_bib17","first-page":"100","article-title":"Meta-analysis","volume":"7","author":"Sharp","year":"1998","journal-title":"Stata Technical Bulletin Reprints"},{"key":"10.1016\/j.ijcard.2008.08.001_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1469-1809.1955.tb01285.x","article-title":"The estimation and significance of the logarithm of a ratio of frequencies","volume":"20","author":"Haldane","year":"1955","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.ijcard.2008.08.001_bib19","series-title":"Methods for meta-analysis in medical research","first-page":"58","author":"Sutton","year":"2000"},{"key":"10.1016\/j.ijcard.2008.08.001_bib20","series-title":"Epidemiology, study design and data analysis","author":"Woodward","year":"1999"},{"key":"10.1016\/j.ijcard.2008.08.001_bib21","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.ijcard.2008.08.001_bib22","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.ijcard.2008.08.001_bib23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2008.08.001_bib24","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2337\/dc05-2415","article-title":"Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)","volume":"29","author":"Knopp","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2008.08.001_bib25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Raikou","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2008.08.001_bib26","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0002-9149(97)00346-9","article-title":"Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS])","volume":"80","author":"Herd","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2008.08.001_bib27","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0002-9149(93)90858-A","article-title":"Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8\u00a0mmol\/liter (200 to 300\u00a0mg\/dl) plus two additional atherosclerotic risk factors","volume":"72","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2008.08.001_bib28","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/eurheartj\/ehi819","article-title":"Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology","volume":"27","author":"Stramba-Badiale","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2008.08.001_bib29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.295.3.306","article-title":"Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials","volume":"295","author":"Berger","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2008.08.001_bib30","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1001\/archinte.166.21.2307","article-title":"Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials","volume":"166","author":"Thavendiranathan","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2008.08.001_bib31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1185\/030079906X167516","article-title":"Impact of gender on statin efficacy","volume":"23","author":"Dale","year":"2007","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.ijcard.2008.08.001_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijcard.2008.11.048","article-title":"Ethical authorship and publishing","volume":"131","author":"Coats","year":"2009","journal-title":"Int J Cardiol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527308009431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527308009431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T17:55:44Z","timestamp":1545760544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527308009431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0167527308009431"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2008.08.001","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}